Sign in

CIK 0001501697

  • Non-accelerated filer
  • Smaller reporting company

X4 Pharmaceuticals, Inc

Sign in to watch
Ticker
XFOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273181608
Phone
+1 857-529-8300
Business address
61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
Former names
Arsanis, Inc.
Open-market buys, last 90 days
$11,884
in 1 filing
Open-market sales, last 90 days
$33,658
in 1 filing

Net −$21,775. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. KIRSKE DAVID −$34K Chief Financial Officer sold 7% of stake
  2. Craig Adam R +$12K Executive Chairman 1 filing
Date Insider Transaction Shares Price Value Owned after
2017-11-15 Clark William D Director Grant or award · Stock Option (right to buy) +7,324 7,324
2017-11-15 Gerngross Tillman U. Director Grant or award · Stock Option (right to buy) +7,324 7,324
2017-11-15 GORDON CARL L Director Grant or award · Stock Option (right to buy) +7,324 7,324
2017-11-15 MCGUIRE TERRANCE Director Grant or award · Stock Option (right to buy) +7,324 7,324
2017-11-15 Ross Michael Jay Director Grant or award · Stock Option (right to buy) +7,324 7,324
2017-11-15 Nessi Claudio Director Grant or award · Stock Option (right to buy) +7,324 7,324
2017-11-15 SCHULMAN AMY W Director Grant or award · Stock Option (right to buy) +7,324 7,324
2017-11-15 MCGIRR DAVID W J Director Grant or award · Stock Option (right to buy) +7,324 7,324
2017-11-15 Alexandria Venture Investments, LLC 10% owner Conversion +225,680 225,680
2017-11-15 Alexandria Venture Investments, LLC 10% owner Conversion · Series D convertible preferred stock −770,249 0

Page 25 of 25 · 490 trades